PFE Dec 2024 26.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:53PM EDT. Market open.
| Previous close | 3.4600 |
| Open | 3.6000 |
| Bid | 3.0000 |
| Ask | 3.2500 |
| Strike | 26.00 |
| Expiry date | 2024-12-20 |
| Day's range | 3.4000 - 3.6000 |
| Contract range | N/A |
| Volume | |
| Open interest | 930 |
Investor's Business DailyPfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Pfizer stock is now above its 50-day line on better-than-expected first-quarter sales. Is PFE stock a buy now?
ZacksRoche's (RHHBY) Inavolisib NDA Gets FDA Priority Review Tag
The FDA grants priority review to Roche's (RHHBY) NDA for the inavolisib combination regimen for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation.
ZacksPfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
© 2024 Yahoo. All rights reserved.